Effects of dopamine (DA) on endogenous phosphorylation of hippocampal proteins and polyphosphoinositides were studied in subcellular fractions from a crude mitocondrial/synaptosomal preparation. DA induced a concentration-dependent decrease in the in vitro phosphorylation of the protein B-50 (--22.1% at 10 -5 M DA), whereas no changes were found in phosphoproteins in other subcellular fractions. Treatment of hippocampal slices with 5 x 10 -4 M DA resulted in a 45.8% increase in post hoc phosphorylation of B-50 in SPM and it affected post hoc phosphorylation of several proteins in a cytosolic fraction. In vitro phosphorylation of SPM with DA (5 x 10 -4 M) increased endogenous TPI phosphorylation (+ 51.6%), whereas treatment of slices with DA (5 x 10 -4 M) resulted in a 39.4% decrease in post hoc TPI phosphorylation. This decrease could be blocked by haloperidol. Significant changes induced by DA (5 x 10 m M) were also found in 32p-incorporation into PA (in vitro: --32.4% and post hoc: + 39.3%), but were not found in DPI labeling. The data provide evidence for DA-induced changes in phosphorylation of proteins and polyphosphoinositides in rat hippocampal SPM.
INTRODUCTION
The phosphorylation of membrane components is thought to play an important role in the regulation of neuronal functions 20,42,47. Both phosphorylated proteins 21 and a special class of phospholipids36, 37, the (poly)phosphoinositides (polyPI), have been implicated in the regulation of synaptic transmission and membrane ion permeability. The enzymes responsible for the protein phosphorylation reactions are largely found in cellular fractions enriched in synaptic plasma membranes (SPM)21, 23. Endogenous phosphorylation in SPM may be regulated directly by neurotransmitters (acetylcholineX2) and neuropeptides (ACTH48; enkephalins2,H), or indirectly by transmitters known to affect intracellular cAMP levels (noradrenaline and dopamine21,42.46; serotoninl4).
Transmitter-receptor interaction may also be involved in the regulation of macromolecular synthesis24. 4a. Electrophysiologica118, autoradiographic 45, behavioral 19 and biochemicalS,6,25, 43 studies point to the existence of a dopaminergic transmitter system or dopamine (DA)-sensitive structures in the hippocampus. Dopaminergic agonists increase the fucosylation of gtucoproteins in hippocampus in vivo 30 and in hippocampal slices 29. Similar results are obtained with slices of the corpus striatum 33, a brain region rich in dopaminergic synapses and receptor sites.
The hippocampal slice has proven to be a suitable model, as it is electrophysiologically well characterized and it appears to retain the biochemical and electrophysiological characteristics of the in vivo system3L In the hippocampal slice it was shown that repetitive electrical stimulation of intact monosynaptic neuronal circuits, which is known to produce longterm potentiation (LTP), induces changes in the phosphorylation state of specific synaptic phosphoproteins3,S-aO, 32 and in polyPI metabolism 1. Whatever the neurochemical mechanism underlying LTP, it is generally accepted that LTP is a reflection of an enhanced synaptic efficacy 7.
Thus, in the hippocampus both phosphorylation of membrane components and fucosylation of glycoproteins appear to be related to neurotransmitter action. Since DA induces changes in fucosylation of hippocampal glycoproteins, we were interested in possible concomitant changes in phosphorylation of membrane proteins and lipids. In this study we describe 0006-8993/84/$03.00 © 1984 Elsevier Science Publishers B.V.
